个人中心
登出
中文简体
返回
-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明,无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
登录后咨询在线客服
回到顶部
12 Health Care Stocks Moving In Friday's Intraday Session
12 Health Care Stocks Moving In Friday's Intraday Session
周五盘中交易时段,12只医疗保健类股走势
Gainers
- Alaunos Therapeutics (NASDAQ:TCRT) shares moved upwards by 22.0% to $2.58 during Friday's regular session. Trading volume for this security as of 13:30 EST is 17.3 million, which is 494.2% of its average full-day volume over the last 100 days. The company's market cap stands at $556.6 million.
- Lannett (NYSE:LCI) shares moved upwards by 15.04% to $0.53. Lannett's stock is trading at a volume of 981.9K shares as of 13:30 EST. This is 544.6% of its average full-day volume over the last 100 days. The company's market cap stands at $22.7 million.
- Alpha Tau Medical (NASDAQ:DRTS) stock moved upwards by 11.11% to $6.2. The current volume of 65.0K shares is 95.5% of Alpha Tau Medical's average full-day volume over the last 100 days (last updated at 13:30 EST). The market value of their outstanding shares is at $426.8 million.
- Anixa Biosciences (NASDAQ:ANIX) shares moved upwards by 10.39% to $4.95. The current volume of 107.7K shares is 187.4% of Anixa Biosciences's average full-day volume over the last 100 days (last updated at 13:30 EST). The company's market cap stands at $151.6 million.
- Genenta Science (NASDAQ:GNTA) stock increased by 7.74% to $5.65. The company's market cap stands at $102.9 million.
- 89bio (NASDAQ:ETNB) shares rose 7.35% to $6.28. Trading volume for this security as of 13:30 EST is 363.5K, which is 32.4% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $245.3 million.
Losers
- Shuttle Pharmaceuticals (NASDAQ:SHPH) stock fell 31.4% to $11.41 during Friday's regular session. The current volume of 11.2 million shares is 218.2% of Shuttle Pharmaceuticals's average full-day volume over the last 100 days (last updated at 13:30 EST). The company's market cap stands at $151.5 million.
- NeuroBo Pharmaceuticals (NASDAQ:NRBO) stock declined by 29.92% to $17.4. The current volume of 593.3K shares is 170.7% of NeuroBo Pharmaceuticals's average full-day volume over the last 100 days (last updated at 13:30 EST). The market value of their outstanding shares is at $15.4 million.
- Comera Life Sciences (NASDAQ:CMRA) stock decreased by 28.86% to $2.54. As of 13:30 EST, this security is trading at a volume of 1.4 million shares, making up 35.0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $48.4 million.
- Midatech Pharma (NASDAQ:MTP) stock fell 20.98% to $0.53. Trading volume for this security as of 13:30 EST is 301.2K, which is 327.3% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $10.3 million.
- Lisata Therapeutics (NASDAQ:LSTA) shares decreased by 20.32% to $4.98. As of 13:30 EST, Lisata Therapeutics's stock is trading at a volume of 283.3K, which is 14.1% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $20.1 million.
- Apexigen (NASDAQ:APGN) shares decreased by 18.83% to $5.78. Trading volume for Apexigen's stock is 174.8K as of 13:30 EST. This is 54.1% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $123.9 million. See Also:
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Gainers
获胜者
- Alaunos Therapeutics (NASDAQ:TCRT) shares moved upwards by 22.0% to $2.58 during Friday's regular session. Trading volume for this security as of 13:30 EST is 17.3 million, which is 494.2% of its average full-day volume over the last 100 days. The company's market cap stands at $556.6 million.
- Lannett (NYSE:LCI) shares moved upwards by 15.04% to $0.53. Lannett's stock is trading at a volume of 981.9K shares as of 13:30 EST. This is 544.6% of its average full-day volume over the last 100 days. The company's market cap stands at $22.7 million.
- Alpha Tau Medical (NASDAQ:DRTS) stock moved upwards by 11.11% to $6.2. The current volume of 65.0K shares is 95.5% of Alpha Tau Medical's average full-day volume over the last 100 days (last updated at 13:30 EST). The market value of their outstanding shares is at $426.8 million.
- Anixa Biosciences (NASDAQ:ANIX) shares moved upwards by 10.39% to $4.95. The current volume of 107.7K shares is 187.4% of Anixa Biosciences's average full-day volume over the last 100 days (last updated at 13:30 EST). The company's market cap stands at $151.6 million.
- Genenta Science (NASDAQ:GNTA) stock increased by 7.74% to $5.65. The company's market cap stands at $102.9 million.
- 89bio (NASDAQ:ETNB) shares rose 7.35% to $6.28. Trading volume for this security as of 13:30 EST is 363.5K, which is 32.4% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $245.3 million.
- 阿拉诺斯疗法 纳斯达克股票代码:TCRT)股价在周五的例行中上涨了22.0%,至2.58美元。截至美国东部标准时间 13:30,该证券的交易量为1730万笔,占过去100天平均全天交易量的494.2%。该公司的市值为5.566亿美元。
- 兰内特 纽约证券交易所代码:LCI)股价上涨了15.04%,至0.53美元。截至美国东部标准时间 13:30,兰内特的股票交易量为98.19万股。这是过去100天平均全天交易量的544.6%。该公司的市值为2,270万美元。
- 阿尔法泰医疗 纳斯达克股票代码:DRTS)股价上涨11.11%,至6.2美元。目前65.0万股的交易量为Alpha Tau Medical过去100天平均全天交易量的95.5%(最后更新时间为美国东部标准时间 13:30)。他们的已发行股票的市值为4.268亿美元。
- 阿尼克萨生物科学 纳斯达克股票代码:ANIX)股价上涨了10.39%,至4.95美元。目前的107.7万股交易量为Anixa Biosciences过去100天平均全天交易量的187.4%(最后更新时间为美国东部标准时间 13:30)。该公司的市值为1.516亿美元。
- 基因科学 纳斯达克股票代码:GNTA)股价上涨7.74%,至5.65美元。该公司的市值为1.029亿美元。
- 89bio 纳斯达克股票代码:ETNB)股价上涨7.35%,至6.28美元。截至美国东部标准时间 13:30,该证券的交易量为363.5万,占过去100天平均全天交易量的32.4%。他们已发行股票的市值为2.453亿美元。
Losers
失败者
- Shuttle Pharmaceuticals (NASDAQ:SHPH) stock fell 31.4% to $11.41 during Friday's regular session. The current volume of 11.2 million shares is 218.2% of Shuttle Pharmaceuticals's average full-day volume over the last 100 days (last updated at 13:30 EST). The company's market cap stands at $151.5 million.
- NeuroBo Pharmaceuticals (NASDAQ:NRBO) stock declined by 29.92% to $17.4. The current volume of 593.3K shares is 170.7% of NeuroBo Pharmaceuticals's average full-day volume over the last 100 days (last updated at 13:30 EST). The market value of their outstanding shares is at $15.4 million.
- Comera Life Sciences (NASDAQ:CMRA) stock decreased by 28.86% to $2.54. As of 13:30 EST, this security is trading at a volume of 1.4 million shares, making up 35.0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $48.4 million.
- Midatech Pharma (NASDAQ:MTP) stock fell 20.98% to $0.53. Trading volume for this security as of 13:30 EST is 301.2K, which is 327.3% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $10.3 million.
- Lisata Therapeutics (NASDAQ:LSTA) shares decreased by 20.32% to $4.98. As of 13:30 EST, Lisata Therapeutics's stock is trading at a volume of 283.3K, which is 14.1% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $20.1 million.
- Apexigen (NASDAQ:APGN) shares decreased by 18.83% to $5.78. Trading volume for Apexigen's stock is 174.8K as of 13:30 EST. This is 54.1% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $123.9 million. See Also:
- 航天制药 纳斯达克股票代码:SHPH)股价在周五的例行交易中下跌31.4%,至11.41美元。目前成交量为1,120万股,是Shuttle Pharmicals过去100天平均全天成交量的218.2%(最后更新时间为美国东部标准时间 13:30)。该公司的市值为1.515亿美元。
- 纽罗博制药 纳斯达克股票代码:NRBO)股价下跌29.92%,至17.4美元。目前成交量为593.3万股,占NeuroBo Pharmicals过去100天平均全天交易量的170.7%(最后更新时间为美国东部标准时间 13:30)。他们已发行股票的市值为1,540万美元。
- Comera 生命科学 纳斯达克股票代码:CMRA)股价下跌28.86%,至2.54美元。截至美国东部标准时间 13:30,该证券的交易量为140万股,占过去100天平均全日交易量的35.0%。他们已发行股票的市值为4,840万美元。
- Midatech Parma 纳斯达克股票代码:MTP)股价下跌20.98%,至0.53美元。截至美国东部标准时间 13:30,该证券的交易量为301.2万,占过去100天平均全天交易量的327.3%。他们已发行股票的市值为1,030万美元。
- 丽莎塔疗法 纳斯达克股票代码:LSTA)股价下跌20.32%,至4.98美元。截至美国东部标准时间 13:30,Lisata Therapeutics的股票交易量为283.3万,是过去100天全天平均交易量的14.1%。他们已发行股票的市值为2,010万美元。
- Apexigen 纳斯达克股票代码:APGN)股价下跌18.83%,至5.78美元。截至美国东部标准时间 13:30,Apexigen股票的交易量为17.48万。这是过去100天平均全天交易量的54.1%。他们已发行股票的市值为1.239亿美元。 另请参阅:
This article was generated by Benzinga's automated content engine and reviewed by an editor.
本文由Benzinga的自动内容引擎生成,并由编辑审阅。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
风险及免责提示
本页的译文内容由软件翻译。Moomoo将竭力但却不能保证翻译内容之准确和可靠,亦不会承担因任何不准确或遗漏而引起的任何损失或损害。
本内容仅用作提供信息及教育之目的,不构成对任何特定证券或投资策略的推荐或认可。本内容中的信息仅用于说明目的,可能不适用于所有投资者。本内容未考虑任何特定人士的投资目标、财务状况或需求,并不应被视作个人投资建议。建议您在做出任何投资于任何资本市场产品的决定之前,应考虑您的个人情况判断信息的适当性。过去的投资表现不能保证未来的结果。投资涉及风险和损失本金的可能性。moomoo对上述内容的真实性、完整性、准确性或对任何特定目的的时效性不做任何陈述或保证。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
知道了
风险及免责提示
本页的译文内容由软件翻译。Moomoo将竭力但却不能保证翻译内容之准确和可靠,亦不会承担因任何不准确或遗漏而引起的任何损失或损害。
本内容仅用作提供信息及教育之目的,不构成对任何特定证券或投资策略的推荐或认可。本内容中的信息仅用于说明目的,可能不适用于所有投资者。本内容未考虑任何特定人士的投资目标、财务状况或需求,并不应被视作个人投资建议。建议您在做出任何投资于任何资本市场产品的决定之前,应考虑您的个人情况判断信息的适当性。过去的投资表现不能保证未来的结果。投资涉及风险和损失本金的可能性。moomoo对上述内容的真实性、完整性、准确性或对任何特定目的的时效性不做任何陈述或保证。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
知道了
抢沙发
0 0 0
赞大爱笑哭社会社会Emm心碎怒
轻触选择心情
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧
点击这里分享给好友
暂无评论,快来抢沙发吧!